{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:24:36Z","timestamp":1782361476403,"version":"3.54.5"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.lfs.2023.121531","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T16:30:15Z","timestamp":1677515415000},"page":"121531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases"],"prefix":"10.1016","volume":"319","author":[{"given":"Emina Karahmet","family":"Sher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"\u0106osovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"D\u017eidi\u0107-Krivi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma Karahmet","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Pinji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farooq","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2023.121531_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102995","article-title":"Immune system activation in polymyalgia rheumatica: which balance between autoinflammation and autoimmunity? A systematic review","volume":"21","author":"Hysa","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.lfs.2023.121531_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","article-title":"Autoimmune and inflammatory diseases following COVID-19","volume":"16","author":"Galeotti","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"14","key":"10.1016\/j.lfs.2023.121531_bb0015","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1021\/acschemneuro.1c00403","article-title":"COVID-19 as a trigger of brain autoimmunity","volume":"12","author":"Gupta","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"24","key":"10.1016\/j.lfs.2023.121531_bb0020","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154886","article-title":"The intersection of COVID-19 and autoimmunity","volume":"131","author":"Knight","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.lfs.2023.121531_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41584-021-00608-z","article-title":"Systemic and organ-specific immune-related manifestations of COVID-19","volume":"17","author":"Ramos-Casals","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.lfs.2023.121531_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645013","article-title":"Autoimmune and rheumatic manifestations associated with COVID-19 in adults: an updated systematic review","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121531_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2023.121531_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.693938","article-title":"COVID-19 mechanisms in the human body\u2014what we know so far","volume":"12","author":"Kumar","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.121531_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155873","article-title":"SARS-CoV-2 triggering autoimmune diseases","volume":"154","author":"Mobasheri","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2023.121531_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cytogfr.2020.05.002","article-title":"COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons","volume":"53","author":"Nile","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.lfs.2023.121531_bb0060","series-title":"Deconstructing Cell Intrinsic Immunity and Host-Pathogen Interactions Using Single-Cell Genomics","author":"Ziegler","year":"2021"},{"key":"10.1016\/j.lfs.2023.121531_bb0065","first-page":"1","article-title":"SARS-CoV-2 and the host cell: a tale of interactions","author":"Pizzato","year":"2022","journal-title":"Front. Virol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121531_bb0070","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","volume":"8","author":"Jose","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19080-6","article-title":"Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19","volume":"11","author":"Carissimo","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/JLB.4COVA1020-703R","article-title":"T cell counts and IL-6 concentration in blood of north african COVID-19 patients are two independent prognostic factors for severe disease and death","volume":"111","author":"Belaid","year":"2022","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2023.121531_bb0085","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1172\/JCI140965","article-title":"SARS\u2013CoV-2\u2013specific T cell responses and correlations with COVID-19 patient predisposition","volume":"130","author":"Sattler","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2023.121531_bb0090","series-title":"Cell Entry Mechanisms of SARS-CoV-2","first-page":"11727","volume":"117(21)","author":"Shang","year":"2020"},{"issue":"2","key":"10.1016\/j.lfs.2023.121531_bb0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jtcme.2020.12.001","article-title":"Anti-COVID-19 drug candidates: a review on potential biological activities of natural products in the management of new coronavirus infection","volume":"11","author":"Prasansuklab","year":"2021","journal-title":"J. Tradit. Complement. Med."},{"issue":"21","key":"10.1016\/j.lfs.2023.121531_bb0100","doi-asserted-by":"crossref","first-page":"12256","DOI":"10.1021\/acs.jmedchem.0c00502","article-title":"Inhibitors of SARS-CoV-2 entry: current and future opportunities","volume":"63","author":"Xiu","year":"2020","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.lfs.2023.121531_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2022.06.005","article-title":"Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health","volume":"28","author":"Doty","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"12","key":"10.1016\/j.lfs.2023.121531_bb0110","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.apsb.2021.05.007","article-title":"SARS-CoV-2 cell entry and targeted antiviral development","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2023.121531_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.152072","article-title":"CD147-spike protein interaction in COVID-19: get the ball rolling with a novel receptor and therapeutic target","volume":"808","author":"Behl","year":"2022","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.lfs.2023.121531_bb0120","series-title":"The Role of Neuropilin-1 in COVID-19","volume":"17(1)","author":"Mayi","year":"2021"},{"issue":"5","key":"10.1016\/j.lfs.2023.121531_bb0125","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/1440-1681.13483","article-title":"Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection","volume":"48","author":"Pan","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121531_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-022-04582-x","article-title":"Contribution of T-and B-cell intrinsic toll-like receptors to the adaptive immune response in viral infectious diseases","volume":"79","author":"Zhang","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.121531_bb0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5114\/pja.2020.99243","article-title":"The immune response to SARS-CoV-2. Focus on severe COVID-19 pathogenesis","volume":"7","author":"Pawliczak","year":"2020","journal-title":"Alergol. Pol. Pol. J. Allergol."},{"key":"10.1016\/j.lfs.2023.121531_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8198963","article-title":"Cytokine storm in COVID-19 patients, its impact on organs and potential treatment by QTY code-designed detergent-free chemokine receptors","volume":"2020","author":"Mustafa","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2023.121531_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.lfs.2023.121531_bb0150","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.dsx.2020.07.005","article-title":"Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: a systematic review","volume":"14","author":"Zaki","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/JLB.3COVA0820-410RRR","article-title":"Cytokine release syndrome in COVID-19: innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex","volume":"109","author":"Petrey","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121531_bb0160","article-title":"Chest x-ray resolution after SARS-CoV-2 infection","volume":"18","author":"Prnjavorac","year":"2021","journal-title":"Med. Glas."},{"issue":"12","key":"10.1016\/j.lfs.2023.121531_bb0165","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S2213-2600(20)30370-2","article-title":"Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study","volume":"8","author":"Grasselli","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2023.121531_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108516","article-title":"Neutrophil extracellular traps (NETs) and Covid-19: a new frontiers for therapeutic modality","volume":"104","author":"Al-Kuraishy","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121531_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2176","article-title":"Covid-19 and kidney injury: pathophysiology and molecular mechanisms","volume":"31","author":"Ahmadian","year":"2021","journal-title":"Rev. Med. Virol."},{"issue":"19","key":"10.1016\/j.lfs.2023.121531_bb0180","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3748\/wjg.v26.i19.2286","article-title":"Liver diseases in COVID-19: etiology, treatment and prognosis","volume":"26","author":"Wu","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0185","first-page":"12","article-title":"Clinical use of an analysis of oxidative stress and IL-6 as the promoters of diabetic polyneuropathy","volume":"18","author":"Karahmet","year":"2021","journal-title":"Med. Glas."},{"key":"10.1016\/j.lfs.2023.121531_bb0190","first-page":"186","article-title":"IDF21-0423 Michigan neuropathy screening for assessing diabetes in participants and correlation to the immune response","author":"Emina","year":"2022","journal-title":"J. Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.lfs.2023.121531_bb0195","series-title":"COVID-19: Clinical Features. UpToDate","author":"McIntosh","year":"2021"},{"key":"10.1016\/j.lfs.2023.121531_bb0200","series-title":"Targeting of Neuroinflammation by Glibenclamide in Covid-19: Old Weapon From Arsenal","first-page":"1","author":"Batiha","year":"2022"},{"key":"10.1016\/j.lfs.2023.121531_bb0205","series-title":"Pirfenidone and Post-Covid-19 Pulmonary Fibrosis: Invoked Again for Realistic Goals","first-page":"2017","volume":"30(6)","author":"Al-Kuraishy","year":"2022"},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"issue":"14","key":"10.1016\/j.lfs.2023.121531_bb0215","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/cvr\/cvab298","volume":"117","author":"Cenko","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"10\u201311","key":"10.1016\/j.lfs.2023.121531_bb0220","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00011-022-01615-w","article-title":"Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for holy grail","volume":"71","author":"Alkhayyat","year":"2022","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.lfs.2023.121531_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110231","article-title":"COVID-19 and the renin-angiotensin system (RAS): a spark that sets the forest alight?","volume":"144","author":"Wiese","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"6","key":"10.1016\/j.lfs.2023.121531_bb0230","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cmi.2020.04.012","article-title":"Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"7","key":"10.1016\/j.lfs.2023.121531_bb0235","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1470-2045(20)30309-0","article-title":"Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study","volume":"21","author":"Tian","year":"2020","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121531_bb0240","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/1389203723666220610124303","article-title":"Calprotectin: the link between acute lung injury and gastrointestinal injury in Covid-19: ban or boon","volume":"23","author":"Al-Kuraishy","year":"2022","journal-title":"Curr. Protein Pept. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121531_bb0245","doi-asserted-by":"crossref","first-page":"76","DOI":"10.31662\/jmaj.2021-0013","article-title":"Clinical manifestations of coronavirus disease 2019","volume":"4","author":"Kutsuna","year":"2021","journal-title":"JMA J."},{"issue":"21","key":"10.1016\/j.lfs.2023.121531_bb0250","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101718118","article-title":"Old vaccines for new infections: exploiting innate immunity to control COVID-19 and prevent future pandemics","volume":"118","author":"Chumakov","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2023.121531_bb0255","first-page":"832","article-title":"Testosterone in COVID-19: an adversary bane or comrade boon. Frontiers in cellular and infection","author":"Al-Kuraishy","year":"2021","journal-title":"Microbiology"},{"issue":"8","key":"10.1016\/j.lfs.2023.121531_bb0260","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/14728222.2020.1783243","article-title":"The cytokine storm of COVID-19: a spotlight on prevention and protection","volume":"24","author":"Pearce","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"12","key":"10.1016\/j.lfs.2023.121531_bb0265","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s00134-020-06141-z","article-title":"Emerging pharmacological therapies for ARDS: COVID-19 and beyond","volume":"46","author":"Horie","year":"2020","journal-title":"Intensive Care Med."},{"issue":"15","key":"10.1016\/j.lfs.2023.121531_bb0270","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021107826","article-title":"SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation","volume":"40","author":"Thorne","year":"2021","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.chom.2018.12.006","article-title":"Innate and adaptive immune memory: an evolutionary continuum in the host\u2019s response to pathogens","volume":"25","author":"Netea","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0280","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41565-020-00810-2","article-title":"Inducing immune tolerance with dendritic cell-targeting nanomedicines","volume":"16","author":"Cifuentes-Rius","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.lfs.2023.121531_bb0285","series-title":"Cellular and Molecular Immunology E-book","author":"Abbas","year":"2021"},{"key":"10.1016\/j.lfs.2023.121531_bb0290","first-page":"1","article-title":"A guide to antigen processing and presentation","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121531_bb0295","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/ajt.15811","article-title":"Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: a systematic review","volume":"20","author":"d'Izarny-Gargas","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.lfs.2023.121531_bb0300","doi-asserted-by":"crossref","unstructured":"T. Xing , Cell tolerance: central and peripheral, Cold Spring Harb. Perspect. Biol., (4): a006957.","DOI":"10.1101\/cshperspect.a006957"},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-018-0083-6","article-title":"Central CD4+ T cell tolerance: deletion versus regulatory T cell differentiation","volume":"19","author":"Klein","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1409-1412","key":"10.1016\/j.lfs.2023.121531_bb0310","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1098\/rstb.2001.0846","article-title":"SC the royal society","volume":"356","author":"Sprent","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. Biol. Sci. Ser. B"},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0315","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imr.12821","article-title":"Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies","volume":"292","author":"Meffre","year":"2019","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.lfs.2023.121531_bb0320","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nri3667","article-title":"Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see)","volume":"14","author":"Klein","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121531_bb0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41577-020-00454-2","article-title":"Rethinking peripheral T cell tolerance: checkpoints across a T cell\u2019s journey","volume":"21","author":"ElTanbouly","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121531_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-017-0152-y","article-title":"Regulatory B cells: the cutting edge of immune tolerance in kidney transplantation","volume":"9","author":"Peng","year":"2018","journal-title":"Cell Death Dis."},{"issue":"542","key":"10.1016\/j.lfs.2023.121531_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aai9192","article-title":"Profiling the origin, dynamics, and function of traction force in B cell activation","volume":"11","author":"Wang","year":"2018","journal-title":"Sci. Signal."},{"issue":"19","key":"10.1016\/j.lfs.2023.121531_bb0340","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.cell.2021.07.025","article-title":"Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike","volume":"184","author":"Tong","year":"2021","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.lfs.2023.121531_bb0345","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nri.2017.19","article-title":"Mechanisms of central tolerance for B cells","volume":"17","author":"Nemazee","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121531_bb1190","first-page":"1570","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121531_bb0350","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/jamaneurol.2016.1637","article-title":"Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis","volume":"73","author":"Damato","year":"2016","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0355","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/imr.12818","article-title":"Self-reactivity on a spectrum: a sliding scale of peripheral B cell tolerance","volume":"292","author":"Tan","year":"2019","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.lfs.2023.121531_bb0360","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4049\/jimmunol.2000377","article-title":"Peripheral tolerance checkpoints imposed by ubiquitous antigen expression limit antigen-specific B cell responses under strongly immunogenic conditions","volume":"205","author":"Brooks","year":"2020","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0365","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/v12010074","article-title":"Factors that govern the induction of long-lived antibody responses","volume":"12","author":"Chackerian","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.lfs.2023.121531_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103012","article-title":"Autoantibodies and SARS-CoV2 infection: the spectrum from association to clinical implication: report of the 15th Dresden symposium on autoantibodies","volume":"21","author":"Damoiseaux","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2023.121531_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102791","article-title":"Molecular mimicry between SARS-CoV-2 and human proteins","volume":"20","author":"Adiguzel","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"62","key":"10.1016\/j.lfs.2023.121531_bb0380","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.lfs.2023.121531_bb0385","article-title":"Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-abs neutralizing type I IFNs","author":"Bastard","year":"2022","journal-title":"Sci. Immunol."},{"issue":"12","key":"10.1016\/j.lfs.2023.121531_bb0390","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.3390\/cells10123592","article-title":"New onset of autoimmune diseases following COVID-19 diagnosis","volume":"10","author":"Gracia-Ramos","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2023.121531_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102506","article-title":"Autoinflammatory and autoimmune conditions at the crossroad of COVID-19","volume":"114","author":"Rodr\u00edguez","year":"2020","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.lfs.2023.121531_bb0400","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.3390\/cells10123291","article-title":"COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges","volume":"10","author":"Dewanjee","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-020-02235-6","article-title":"Brain arteriolosclerosis","volume":"141","author":"Blevins","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121531_bb0410","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2023.121531_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.103249","article-title":"COVID-19 associated vasculitis: a systematic review of case reports and case series","volume":"74","author":"Wong","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.lfs.2023.121531_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118431","article-title":"SARS-CoV-2 and coagulation disorders in different organs","volume":"260","author":"Vinayagam","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2023.121531_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584241","article-title":"Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome","volume":"11","author":"Borghi","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0430","article-title":"Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots","volume":"5","author":"Tung","year":"2021","journal-title":"Rheumatol. Adv. Pract."},{"issue":"9","key":"10.1016\/j.lfs.2023.121531_bb0435","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/jth.15455","article-title":"Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19","volume":"19","author":"Hollerbach","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.lfs.2023.121531_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103206","article-title":"COVID-19 and the antiphospholipid syndrome","volume":"21","author":"Serrano","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.lfs.2023.121531_bb0445","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/jth.14192","article-title":"McMaster RARE-bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome","volume":"16","author":"Legault","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.lfs.2023.121531_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103055","article-title":"Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): descriptive analysis from the \u201cCAPS registry\u201d","volume":"21","author":"L\u00f3pez-Benjume","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2023.121531_bb0455","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.thromres.2018.07.011","article-title":"Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): a personal perspective","volume":"169","author":"Pengo","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.lfs.2023.121531_bb0460","article-title":"Thrombosis and COVID-19 pneumonia: the clot thickens!","volume":"56","author":"Price","year":"2020","journal-title":"Eur. Respiratory Soc."},{"key":"10.1016\/j.lfs.2023.121531_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100527","article-title":"Multisystem inflammatory syndrome in children: a systematic review","volume":"26","author":"Ahmed","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"32","key":"10.1016\/j.lfs.2023.121531_bb0470","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.15585\/mmwr.mm6932e2","article-title":"COVID-19\u2013associated multisystem inflammatory syndrome in children\u2014United States, March\u2013July 2020","volume":"69","author":"Godfred-Cato","year":"2020","journal-title":"Morb. Mortal. Wkly Rep."},{"issue":"14","key":"10.1016\/j.lfs.2023.121531_bb0475","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1177\/09612033211062523","article-title":"COVID-19 and antiphospholipid antibodies: a position statement and management guidance from AntiPhospholipid syndrome Alliance for clinical trials and InternatiOnal networking (APS ACTION)","volume":"30","author":"Wang","year":"2021","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.lfs.2023.121531_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266809","article-title":"The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: a nationwide cohort from the US using the cerner real-world data","volume":"17","author":"Qeadan","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121531_bb0485","series-title":"Impact of COVID-19 on the Thyroid Gland: An Update","first-page":"803","volume":"22(4)","author":"Scappaticcio","year":"2021"},{"key":"10.1016\/j.lfs.2023.121531_bb0490","series-title":"The Cytokine Storm and Thyroid Hormone Changes in COVID-19","first-page":"891","volume":"44(5)","author":"Croce","year":"2021"},{"issue":"12","key":"10.1016\/j.lfs.2023.121531_bb0495","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1080\/10428194.2020.1788017","article-title":"Hematological manifestations of COVID-19","volume":"61","author":"Mina","year":"2020","journal-title":"Leuk. Lymphoma"},{"issue":"7","key":"10.1016\/j.lfs.2023.121531_bb0500","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121531_bb0505","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2023.121531_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first international consensus meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.lfs.2023.121531_bb0515","doi-asserted-by":"crossref","first-page":"634208","DOI":"10.3389\/fmed.2021.634208","article-title":"Skin manifestations in COVID-19 patients: Are they indicators for disease severity? A systematic review","volume":"8","author":"Jamshidi","year":"2021","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.121531_bb0520","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/wound.2020.1309","article-title":"Cutaneous manifestations of COVID-19: a systematic review","volume":"10","author":"Singh","year":"2021","journal-title":"Adv. Wound Care"},{"issue":"13","key":"10.1016\/j.lfs.2023.121531_bb0525","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","article-title":"Pharmaco-immunomodulatory therapy in COVID-19","volume":"80","author":"Rizk","year":"2020","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0530","doi-asserted-by":"crossref","first-page":"103","DOI":"10.18502\/jovr.v16i1.8256","article-title":"Ocular manifestations of COVID-19: a systematic review and meta-analysis","volume":"16","author":"Nasiri","year":"2021","journal-title":"J. Ophthalmic Vision Res."},{"key":"10.1016\/j.lfs.2023.121531_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2021.102191","article-title":"Ocular manifestations in COVID-19 patients: a systematic review and meta-analysis","volume":"44","author":"Zhong","year":"2021","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.lfs.2023.121531_bb0540","series-title":"StatPearls [Internet]","article-title":"Ophthalmic manifestations of coronavirus (COVID-19)","author":"Hu","year":"2022"},{"issue":"11","key":"10.1016\/j.lfs.2023.121531_bb0545","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","article-title":"Lifting the mask on neurological manifestations of COVID-19","volume":"16","author":"Pezzini","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2023.121531_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577658","article-title":"Neurological manifestations of COVID-19: a comprehensive literature review and discussion of mechanisms","volume":"358","author":"Johansson","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121531_bb0555","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.chest.2020.04.019","article-title":"Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic","volume":"158","author":"Wong","year":"2020","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.lfs.2023.121531_bb0560","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jiac.2021.11.010","article-title":"Post-COVID-19 interstitial lung disease presenting with profound hypoxemia: report of three cases demonstrating a good response to high-dose corticosteroid therapy","volume":"28","author":"Uemasu","year":"2022","journal-title":"J. Infect. Chemother."},{"issue":"5","key":"10.1016\/j.lfs.2023.121531_bb0565","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1513\/AnnalsATS.202008-1002OC","article-title":"Persistent post\u2013COVID-19 interstitial lung disease. An observational study of corticosteroid treatment","volume":"18","author":"Myall","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"5","key":"10.1016\/j.lfs.2023.121531_bb0570","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0575","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/dc09-0880","article-title":"Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer","volume":"33","author":"Ehrlich","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.lfs.2023.121531_bb0580","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/2090598X.2021.1955554","article-title":"The impact of COVID-19 on the male reproductive tract and fertility: a systematic review","volume":"19","author":"Sengupta","year":"2021","journal-title":"Arab. J. Urol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121531_bb0585","doi-asserted-by":"crossref","DOI":"10.1111\/and.13914","article-title":"Review of COVID-19 and male genital tract","volume":"53","author":"Sheikhzadeh Hesari","year":"2021","journal-title":"Andrologia"},{"issue":"2","key":"10.1016\/j.lfs.2023.121531_bb0590","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1530\/REP-20-0523","article-title":"Evaluating the impact of COVID-19 on male reproduction","volume":"161","author":"Tian","year":"2021","journal-title":"Reproduction"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:35:50Z","timestamp":1736382950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":119,"alternative-id":["S0024320523001650"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121531","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"121531"}}